Building on the strong momentum established at the Vaccine I-VI meetings, our goal is to gather key leaders in the field to discuss progress and technological challenges facing vaccine development and manufacturing for global needs. The meeting is organized by scientists from academia and industry in an intimate setting, and differentiates itself from commercial conferences by providing very high quality, cutting-edge scientific content. This format is an outstanding opportunity for exchange of ideas among scientists from diverse backgrounds and with a representation from different regions of the world. Many national and international organizations including The Bill and Melinda Gates Foundation as well as the vaccine industry have supported the previous meetings in this series. We will frequently update our website to inform about confirmed speakers, workshops, abstract submission and registration information.